07. March 2016 28 August 2016- 01 September 2016 Buenos Aires, Argentina More Information
FDA The FDA-approved excipient N,N-dimethylacetamide improves survival and attenuates inflammatory pathways in a murine model of endotoxemia 1. May 2026
Artificial Intelligence Empowering the pharmaceutical workforce for the digital future 30. April 2026
Asahi Kasei Comparative Study of Microcrystalline Cellulose Grades on Process Robustness in High Shear Granulation 30. April 2026